Analysts Set Palvella Therapeutics, Inc. (NASDAQ:PVLA) Price Target at $198.07

Shares of Palvella Therapeutics, Inc. (NASDAQ: PVLA - Get Free Report) have received an average rating of "Moderate Buy" from the fifteen analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, thirteen have assigned a buy rating and one has issued a strong buy rating on the